"The ASX doesn’t offer much in the way of ophthalmology stocks...

  1. 14,455 Posts.
    lightbulb Created with Sketch. 1240
    "The ASX doesn’t offer much in the way of ophthalmology stocks so I guess it’s rather unfamiliar with them, but OPT (assuming the result is good) is easily a $10-$20 stock in the making IMO, likely even higher."


    $10 to $20 rolleyes.png
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.